[Antibacterial agent Oftaquix efficacy in cataract phacoemulsification].

Clinical study is performed to estimate the efficacy of Oftaquix in cataract phacoemulsification with intraocular lens (IOL) implantation. Obtained results show that Oftaquix prescription two days before surgery allows to eliminate bacterial agents from conjunctival cavity on the day of surgery. Significant and stable antibacterial effect is demonstrated.

[Possibilities of immunosuppressive therapy in reconstructive keratoplasty (experience gained in the use of cyclosporin)].

Cyclosporin was used for preventing the graft rejection reaction after reconstructive operations on the anterior segment of the eye. Analysis of the results of surgical treatment of patients with vascularized corneal leukomas of different etiology in 23 patients (25 eyes) who received postoperative oral cyclosporin therapy and in 25 patients to whom this drug was instilled showed that cyclosporin promoted transparent healing of the keratotransplant and its use was not associated with serious side effects.